Journal article
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial
Abstract
BACKGROUND: We conducted a phase II trial that evaluated the tolerability and efficacy of combining lenalidomide with melphalan in previously untreated patients with multiple myeloma who were not candidates for autologous stem cell transplantation.
METHODS: After a run-in phase of 6 patients, we planned to conduct a randomized phase II selection-design trial that assessed 2 dose levels of lenalidomide, given days 1 to 21, combined with …
Authors
White DJ; Bahlis NJ; Marcellus DC; Belch A; Stewart AK; Chen C; Kovacs MJ; Macdonald DA; Reece DE; Reiman T
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 13, No. 1, pp. 19–24
Publisher
Elsevier
Publication Date
February 2013
DOI
10.1016/j.clml.2012.08.009
ISSN
2152-2650